Status:
ACTIVE_NOT_RECRUITING
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this study is to see if a telemedicine group doctor's appointment is a practical (feasible) and acceptable method for following people with prostate cancer being managed with active sur...
Eligibility Criteria
Inclusion
- A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer
- Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2)
- Clinical T stage ≤T2B
- Access to a device with Zoom
- Ability to speak and understand English
Exclusion
- Plan to undergo a prostate biopsy at this follow-up visit
Key Trial Info
Start Date :
June 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2026
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT05416996
Start Date
June 5 2022
End Date
June 1 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065